TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Vaxxinova Norway AS
Closing information (x1000 SEK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
12,866
|
10,755
|
8,461 |
Financial expenses |
2,600
|
90
|
302 |
Earnings before taxes |
-26,829
|
-17,223
|
-21,950 |
Total assets |
62,530
|
21,276
|
29,359 |
Current assets |
17,987
|
11,714
|
27,138 |
Current liabilities |
33,326
|
3,873
|
3,040 |
Equity capital |
15,479
|
580
|
13,425 |
- share capital |
101
|
103
|
99 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
24.8%
|
2.7%
|
45.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
-208.5%
|
-160.1%
|
-259.4% |
Return on assets (ROA) |
-38.7%
|
-80.5%
|
-73.7% |
Current ratio |
54.0%
|
302.5%
|
892.7% |
Return on equity (ROE) |
-173.3%
|
-2969.5%
|
-163.5% |
Change turnover |
2,338
|
1,977
|
-27,877 |
Change turnover % |
22%
|
23%
|
-77% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.